China's medical products regulator has given conditional approval for Pfizer's Covid-19 treatment Paxlovid, making it the first pill approved in the country to treat the disease.

The company's direct-to-consumer sales in China rose 35% in the third quarter, compared with an 85.9% jump in the second quarter

The recommendation, which sent Innovent shares down, raises concerns for other Chinese drugmakers seeking to bring products to the US market

The transport and financial hub is forecast to grow 3-5% this year after expanding at its fastest annual pace in over a decade in 2021

The state has been closed off to the rest of the country for about two years, taking advantage of its natural isolation to keep cases low

The global financial hub will report at least 1,325 new coronavirus cases on Friday, broadcaster TVB reported, a new record

International passenger travel in the Asia-Pacific region was down 93% from pre-pandemic levels last year, leaving airlines heavily reliant on freight for revenue

Analysis found that 38% of the credits - equivalent to 73 million tonnes of CO2 - were over five years old, while more than 4% were at least 10 years old

The industry was beset by a liquidity crunch in the past year and only a few companies expressed interest in joining the Test & Go programme

Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement

Hong Kong's daily Covid infections nearly doubled to a record 1,161 cases on Wednesday as the global financial hub battles a rapid surge

Tourists from about 150 territories allowed to visit the Philippines visa-free will be able to enter for the first time in nearly two years